Results 1 to 10 of about 23,750 (257)

Foot-and-mouth disease virus-like particle mRNA vaccine induces strong humoral and cellular immunity [PDF]

open access: yesApplied Microbiology and Biotechnology
Foot-and-mouth disease (FMD) is a major animal infectious disease that has garnered significant international attention. Currently, conventional inactivated vaccines and virus-like particle (VLP) vaccines primarily induce protective immune responses ...
Haiyun Liu   +9 more
doaj   +2 more sources

Evaluation of cellular immune response and biosafety of SV40 virus-like particle in tumor immunotherapy [PDF]

open access: yesJournal of Materials Science: Materials in Medicine
Virus-like particle (VLP) holds great promise for applications in vaccines and tumor immunotherapy. However, their clinical translation has been limited by a lack of comprehensive in vivo studies on immune responses and antigenic toxicity. In this study,
Ting He   +6 more
doaj   +2 more sources

THE INFLUENCE OF THE PERFORATION DENSITY AND DAMAGED ZONE PERMEABILITY ON A GAS WELL PRODUCTION [PDF]

open access: yesRomanian Journal of Petroleum & Gas Technology, 2022
The exploitation of wellbore condensate deposits must be carried out in such a way that both water and condensate from the productive layer are not entrained during extraction.
Alexandra Catalina Damascan   +2 more
doaj   +1 more source

Chimeric MrNV-GE11-VLPs serve as a nano-container to deliver Doxorubicin into cancer cells [PDF]

open access: yesSongklanakarin Journal of Science and Technology (SJST), 2022
We have reported that virus-like particle from shrimp virus, MrNV-VLP, effectively encapsulates and delivers plasmid DNA and dsRNA into Sf9 insect cells and shrimp tissues.
Khwanthana Grataitong   +4 more
doaj   +1 more source

Production of HPV16-L1 through BL21/pET32a expression system [PDF]

open access: yesJournal of Kerman University of Medical Sciences, 2023
Introduction: The Human papillomaviruses (HPV) main capsid protein L1 is naturally capable to self-assemble as virus-like particles (VLPs). There are different recombinant protein expression systems such as bacteria, yeast, insect, plant, and mammalian ...
Sanaz Jahandideh   +3 more
doaj   +1 more source

saRNA vaccine expressing membrane-anchored RBD elicits broad and durable immunity against SARS-CoV-2 variants of concern

open access: yesNature Communications, 2023
Several vaccines have been widely used to counteract the global pandemic caused by SARS-CoV-2. However, due to the rapid emergence of SARS-CoV-2 variants of concern (VOCs), further development of vaccines that confer broad and longer-lasting protection ...
Mai Komori   +17 more
doaj   +1 more source

High Coverage Camera-assisted Received Signal Assisted Algorithm in Indoor Visible Light Positioning Systems

open access: yesGuangtongxin yanjiu, 2022
This paper proposes a novel Non-linear Camera Assisted-Received Signal Strength (nCA-RSS) algorithm. The basic idea of nCA-RSS is to simultaneously utilize camera and Photo-Diode (PD) to capture visual information and signal strength information to ...
Song-lin JIA   +3 more
doaj   +1 more source

Enveloped virus-like particles as a platform for vaccine development

open access: yesInternational Journal of Noncommunicable Diseases, 2021
Vaccination is the most effective approach in preventing and controlling the global public health threat of infectious diseases. Enveloped virus-like particles (eVLPs) offer advantages over other subunit vaccines because of their self-adjuvanting ...
Francisco Diaz-Mitoma
doaj   +1 more source

The study of neuraminidase immunity in protection against secondary bacterial pneumonia induced by S. aureus after influenza infection in mice

open access: yesЖурнал микробиологии, эпидемиологии и иммунобиологии, 2021
Introduction. Pneumonia often occurs secondary to influenza infection and accounts for a large proportion of the morbidity and mortality associated with seasonal and pandemic influenza outbreaks.
I. A. Leneva   +5 more
doaj   +1 more source

Designing a therapeutic hepatitis B vaccine to circumvent immune tolerance

open access: yesHuman Vaccines & Immunotherapeutics, 2020
An effective prophylactic hepatitis B virus (HBV) vaccine has long been available but is ineffective for chronic infection. The primary cause of chronic hepatitis B (CHB) and greatest impediment for a therapeutic vaccine is the direct and indirect ...
DC Whitacre   +11 more
doaj   +1 more source

Home - About - Disclaimer - Privacy